financetom
Business
financetom
/
Business
/
Enthusiast Gaming Secures $20 Million Term Loan to Boost Growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enthusiast Gaming Secures $20 Million Term Loan to Boost Growth
Jul 15, 2024 5:32 AM

08:02 AM EDT, 07/15/2024 (MT Newswires) -- Enthusiast Gaming Holdings ( EGLXF ) said on Monday that it secured a four-year, $20 million non-revolving term loan from lenders led by Beedie Investments Ltd.

The company said it will use the funds for growth capital and working capital purposes.

"This strategic investment significantly bolsters our financial position, providing $20 million of additional liquidity, which will enable us to accelerate our vision of uniting gaming enthusiasts globally and delivering exceptional value to our partners and communities," said Adrian Montgomery, interim CEO and board chairman of Enthusiast Gaming ( EGLXF ).

The loan has a fixed interest rate of 14% per annum calculated and payable monthly in arrears.

While there is at least $2.5 million under the term loan outstanding to Beedie Capital or if Beedie Capital owns, directly or indirectly, 10% or more of Enthusiast Gaming ( EGLXF ) on a partially-diluted basis, Beedie Capital will be entitled to have an observer attend each meeting of Enthusiast Gaming's ( EGLXF ) board.

Beedie Capital can nominate one board member of Enthusiast Gaming ( EGLXF ) if its stake in the company reaches at least 10%.

"With the operations of the company now effectively self-sustaining, we expect this extra capital to unlock significant growth opportunities," Montgomery said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Armata Says FDA Grants Qualified Infectious Disease Product Designation to Complicated Bacteremia Treatment
Armata Says FDA Grants Qualified Infectious Disease Product Designation to Complicated Bacteremia Treatment
Mar 11, 2026
07:41 AM EST, 02/23/2026 (MT Newswires) -- Armata Pharmaceuticals ( ARMP ) said Monday the US Food and Drug Administration has granted its experimental AP-SA02 candidate for intravenous use as a qualified infectious disease product for adjunct treatment of complicated bacteremia. The designation covers bacteremia caused by methicillin-sensitive Staphylococcus aureus or methicillin resistant S. aureus. The designation makes the product...
Blackstone Life Sciences to Co-Fund Leukemia Drug Trials
Blackstone Life Sciences to Co-Fund Leukemia Drug Trials
Mar 11, 2026
07:41 AM EST, 02/23/2026 (MT Newswires) -- Blackstone Life Sciences (BX) said Monday it established a research financing agreement to advance the clinical development of bleximenib, an investigational drug to treat acute myeloid leukemia. Blackstone and Johnson & Johnson ( JNJ ) will jointly finance a portion of current and upcoming trials evaluating bleximenib, the company said. Bleximenib is an...
BRIEF-Stanley Martin Homes To Acquire United Homes Group
BRIEF-Stanley Martin Homes To Acquire United Homes Group
Mar 11, 2026
Feb 23 (Reuters) - United Homes Group ( UHG ) ​Inc: * STANLEY ‌MARTIN HOMES ⁠TO ACQUIRE UNITED ⁠HOMES ‌GROUP * ‌UNITED HOMES GROUP ​INC - ‌ALL-CASH DEAL VALUES UNITED ​HOMES AT $221 ​MILLION * ‌UNITED HOMES GROUP INC - CO'S ⁠SHAREHOLDERS TO ⁠RECEIVE $1.18 PER SHARE IN CASH UNDER ⁠DEAL * ‌UNITED ‌HOMES GROUP ⁠INC - UPON COMPLETION OF...
InMode to Discontinue Potential Transaction Process
InMode to Discontinue Potential Transaction Process
Mar 11, 2026
07:39 AM EST, 02/23/2026 (MT Newswires) -- InMode ( INMD ) said Monday it will discontinue the process of a potential transaction following a review of proposals by the company's independent transaction committee. The committee concluded that none of the final proposals were adequate or in the best interests of the company and its shareholders, InMode ( INMD ) said....
Copyright 2023-2026 - www.financetom.com All Rights Reserved